Among effector T cells (Teffs), both T helper (Th) 1 and Th17 cells, which produce IFNγ and IL-17, respectively, have been implicated in the pathogenesis of experimental colitis, whereas regulatory T cells (Tregs) inhibit colitis development [5–7]. This evidence concerns the gene IL17A and colitis.